article thumbnail

A Review of Oral Cephalosporins for Common Outpatient Infections

Pharmacy Times

First-generation oral cephalosporins (ie, cephalexin and cefadroxil) have excellent coverage of methicillin-susceptible S aureus and Streptococcus spp, making them ideal agents for treatment. Typically, empiric coverage for UTIs includes Escherichia coli and Klebsiella pneumoniae.

article thumbnail

Health insurer Excellus will not fund Alzheimer’s drug Aduhelm

pharmaphorum

Health insurer Excellus BlueCross BlueShield has said it will not cover treatment with Biogen and Eisai’s new Alzheimer’s disease drug Aduhelm because it has not been shown to be medically effective. The post Health insurer Excellus will not fund Alzheimer’s drug Aduhelm appeared first on.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Disease of the Month: Age-Related Macular Degeneration (AMD)

PharmaShots

It includes various tests such as, visual acuity test (for clarity), visual field test (for peripheral vision), tonometry test (pressure in eyes), pupil response test (way of lights enter into eyes) Optical Coherence Tomography: A non-invasive retina imaging test that uses light waves to take high resolution cross-section pictures of retina.

article thumbnail

NHC Submits Comments to CMS RE CY 2026 Policy & Technical Changes to MA and Part D Proposed Rule

Putting Patients First Blog

Coverage of Anti-Obesity Medications (AOMs) The NHC applauds CMS for aligning with the medical community and proposing to recognize obesity as a chronic disease and allow Medicare Part D coverage for AOMs. Below, we provide detailed comments and recommendations on key provisions of the proposed rule.